| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 |
| filingDate |
2011-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94278d759439d848e85a745222d877e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfe1e99f2163aba783e121f810a7da6a |
| publicationDate |
2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2011226967-A1 |
| titleOfInvention |
Anti-DLL4 antibodies and methods using same |
| abstract |
The invention provides anti-DLL4 antibodies, and compositions comprising and methods of using these antibodies. 1200 - -0- PBS MDA-MB-435 --- c--- Anti-DIl4 Tumor 800 Volume (mm 3 ) 600- P=0.04 FIG 9d 0 30 40 50 60 Days 1200 --- PBS MV-522 ------ Anti-VEGF 1000 - -- Anti-Dl14 - -f - Anti-VEGF/Anti-Di14 Tumor 800 Volume * P=0.001 (mm 3) 600- P=0.001 P=0.00001 400- 6 200 - - FIG. 9e 0 5 10 15 20 25 30 35 Days 600 - PBS WEH13 --- --- Anti-VEGF - + - Anti-DI14 Tumor Volume 400- P0.0002 (mm3) 200- .O FIG. 9f 100- 1 4 6 8 10 12 14 Days |
| priorityDate |
2006-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |